| Similar Articles |
|---|
 |
Salon.com
January 5, 2001
Daniel Forbes |
New Mexico thumbs its nose at the war on drugs A panel convened by Gov. Gary Johnson calls for the legalization of marijuana and a shift in focus from penal measures to treatment for drug offenders...   |
Salon.com
April 24, 2001
Jake Tapper |
Virtually NORML Gov. Gary Johnson comes to Washington hoping to find converts to his anti-drug war crusade. He leaves one frustrated man... |
Salon.com
January 17, 2001
Dawn MacKeen |
Could Ashcroft roll back drug policy reform? Bush's choice for attorney general might halt efforts to emphasize treatment over incarceration, opponents fear... |
Reason
January 2001
Michael W. Lynch |
America's Most Dangerous Politician I've been in New Mexico less than 10 minutes when I realize that no ordinary politician rules the Land of Enchantment... |
Salon.com
February 22, 2000
Michael Massing |
The elephant in the room Presidential candidates are silent on the failure of the U.S. war on drugs. |
Salon.com
October 2, 2000
Arianna Huffington |
Disenfranchised Young black men get singled out among drug offenders for the harshest punishment, then they lose their right to vote. With laws like this, who needs Jim Crow? |
The Motley Fool
August 10, 2010
Brian Orelli |
When the Disease Matters Most in Drug Approval Glaxo's and Valeant's Potiga will go before an FDA advisory committee tomorrow. |
Reason
February 2001
Nick Gillespie |
Bill Clinton's Exit Interviews The outgoing president enters his final spin cycle... |
The Motley Fool
June 23, 2010
Brian Orelli |
Duo of Diabetes Drug Deals Make J&J Better Licensing deals add to Johnson & Johnson's diabetes franchise. |
Salon.com
January 12, 2001
Daniel Forbes |
Ashcroft's nephew got probation after major pot bust Although his arrest for growing 60 plants could have landed him in federal prison, Alex Ashcroft was tried in state court and avoided jail, despite his uncle's crusade for tougher federal drug laws and mandatory prison sentences. |
Salon.com
July 31, 2000
Bruce Shapiro |
Hard time for soft crimes Two million Americans are locked up, most for nonviolent drug offenses. Some maverick Republicans -- yes, Republicans -- are trying to change that. |
The Motley Fool
September 27, 2010
Brian Orelli |
This Recall Is Different -- In a Good Way Johnson & Johnson strikes again, but it's not so bad this time. |
Salon.com
August 30, 2000
Arthur Allen |
Portrait of a drug czar Gen. Barry McCaffrey drives his government office like a lockstep battalion, but some contend his ruthless schedule and egomaniacal ways are only hurting his effort to bring sanity to America's drug policy. |
Salon.com
February 14, 2001
Earl Ofari Hutchinson |
Another pardon that stinks Clinton pardoned a well-connected cocaine kingpin -- while letting countless low-level, mostly black and Latino, dealers rot in prison... |
| AskMen.com |
The War On The War On Drugs Mexico enacted a controversial law Thursday decriminalizing possession of small amounts of marijuana, cocaine, heroin and other drugs while encouraging free government treatment for drug dependency. |
The Motley Fool
February 22, 2010
Brian Orelli |
So Long, See You in Arbitration After another rejection, Johnson & Johnson and Basilea call it quits. |
The Motley Fool
April 26, 2011
Brian Orelli |
We Hate Your Drug. And That's a Good Thing. This one's a pain for the clinical trial participants. |
The Motley Fool
March 31, 2011
Brian Orelli |
Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good. |
The Motley Fool
September 15, 2010
Brian Orelli |
Drug Approved. Now Let's Sell This Baby! With ink still wet on its FDA approval, Savient continues its plan to find a buyer. |
The Motley Fool
March 8, 2010
Brian Orelli |
Really? A 59% Share Price Jump for That? Justified or not, InterMune skyrockets ahead of an FDA panel meeting. |
Reason
January 2009
Matt Welch |
Obama's Numbers The president-elect has promised to make his math add up. Therein lies a glimmer of possibility. |
The Motley Fool
April 21, 2011
Brian Orelli |
Tysabri Means Everything to Biogen and Elan ... for Now It's rare to find a drug that affects two companies as much as Tysabri does Biogen Idec and Elan. |
The Motley Fool
September 10, 2010
Brian D. Pacampara |
A Potential Blockbuster Roars Ahead Johnson & Johnson made a good choice to purchase Cougar Biotechnology. |
The Motley Fool
July 30, 2010
Brian Orelli |
A Faster Pathway to Drug Approvals A thinktank called the Pacific Research Institute has proposed letting drugs approved by the European Medicines Authority onto the market in the U.S. before the Food and Drug Administration has approved the drugs. |
The Motley Fool
July 13, 2010
Brian Orelli |
A Triple Delight: 3 Stocks All Up More Than 10% What's good for the obese goose is good for the gander when it comes to new drug treatments for losing weight. |
The Motley Fool
January 21, 2011
Brian Orelli |
Mark Your Calendar, Drug Investors Vertex announces that the Food and Drug Administration has accepted its New Drug Application to market telaprevir. |
Salon.com
May 12, 2001
Katharine Mieszkowski |
What has Barry McCaffrey been smoking? The former drug czar goes dot-com with an Internet company that charges $1,200 for online drug treatment... |
The Motley Fool
January 7, 2010
Brian Orelli |
Warning: Potential Anemic Growth Ahead Anemia-drug makers get more scrutiny from the FDA. |
Salon.com
March 27, 2000
Fiona Morgan |
"Humanitarian cease-fire" in the war on drugs A Maine sheriff wants the Legislature to let authorities dole out confiscated pot to people who need medicinal marijuana. |
Reason
March 2001
Michael W. Lynch |
D.C. Downers In which our man in Washington listens to the drug czar babble and learns why we can't afford tax cuts... |
The Motley Fool
May 24, 2011
Brian Orelli |
J&J Approved, but Needs Help From a Friend The HIV combo product is the key. |
The Motley Fool
March 28, 2011
Brian Orelli |
Investors Jump for Yervoy! The Food and Drug Administration approval of Bristol-Myers Squibb's Yervoy came with some surprising labeling news. |
The Motley Fool
January 26, 2010
Brian Orelli |
Timing Is Everything for Amgen Amgen is counting on osteoporosis drug Prolia for a successful 2010. |
Salon.com
October 12, 2000
Arthur Allen |
Drug war politics The presidential candidates have not widely touted their plans to deal with drug abuse. Is it because of their own suspect histories? |
The Motley Fool
June 11, 2010
Brian Orelli |
Pfizer and Bristol Coagulate Against Clots Let's see how apixaban does against warfarin before we break out the "blockbuster" stamp. |
BusinessWeek
August 26, 2010
Jens Erik Gould |
In Mexico, a Call to Legalize Drugs Mexico is publicly debating the idea of legalizing drug use to weaken the cartels. It would be an effective step only if the U.S. did the same. |
The Motley Fool
June 4, 2010
Brian Orelli |
Out With Drugs, in With Medical Devices Johnson & Johnson's movement in medical devices and diagnostics is headed in the right direction, but whether Johnson & Johnson is a buy depends a lot on how it handles its current drug problem. Unfortunately investors can't have one without the other. |
Reason
February 2009
David Weigel |
Czar Wars Don't expect an Obama administration to eliminate the new post of intellectual property watchdog |
Salon.com
January 11, 2001
Eric Boehlert |
Get Ronnie White, Round 2 In their battle for Attorney General-designate John Ashcroft, Republicans are once again attacking the Missouri Supreme Court justice whose federal judgeship Ashcroft scuttled... |
The Motley Fool
May 20, 2010
Brian Orelli |
FDA Transparency! A Big Win for Investors The Food and Drug Administration has possibly just made things easier for investors. Let's just hope drug companies don't shoot it down. |
The Motley Fool
May 2, 2011
Brian Orelli |
Prostate Cancer Drug Roars Ahead Johnson & Johnson's buy of Cougar paid off, but look in the rear view mirror. |
Chemistry World
July 16, 2010
Matt Wilkinson |
Bittersweet victory for GSK's Avandia GlaxoSmithKline has received a muted 'thumbs up' from a US regulatory advisory panel for its much-maligned Type 2 diabetes drug Avandia (rosiglitazone), making it likely the US Food and Drug Administration will allow the UK-based pharma giant to continue selling the drug in the US. |
The Motley Fool
August 18, 2010
Brian Orelli |
No Pain Here as Jazz Shares Rocket Investors are all jazzed up about Jazz Pharmaceuticals |
The Motley Fool
January 29, 2010
Brian Orelli |
How to Make Billions of Dollars Without Really Trying Lackluster Alzheimer's drugs have been doing it for years. |
Salon.com
January 8, 2001
Eric Boehlert |
John Ashcroft's big mistake He denied Ronnie White a federal judgeship for being soft on crime, when his real grudge was against his pro-choice politics -- and the move cost him his Senate seat... |
The Motley Fool
October 19, 2010
Brian Orelli |
When the Status Quo Is a Big Win The lack of an FDA rejection will do just fine. Amgen and Johnson & Johnson seemed to get through the FDA advisory panel process without much problem yesterday. |
The Motley Fool
March 4, 2010
Brian Orelli |
Best in Class ... For Now Sanofi's new prostate cancer drug is better than nothing. |
The Motley Fool
May 2, 2011
Tim Beyers |
Spectrum Pharmaceuticals Shares Popped: What You Need to Know Shares of Spectrum Pharmaceuticals rose as much as 14% in intraday trading after the Food and Drug Administration approved Fusilev as a colon cancer treatment. |
The Motley Fool
February 28, 2011
Brian Orelli |
Look Out for Big Growth From This Drug Regeneron's ultra-orphan drug Arcalyst takes a step forward toward a wider audience. |
Salon.com
May 17, 2001
Arianna Huffington |
Bush's drug two-faced drug war The president claims treatment is the best way to lower the demand for drugs. So why is his new drug czar so obsessed with punishment and prisons? |
